Reinfusion of aspirated pericardial blood during CPB. Part II. Laparotomy sponges are hazardous parts of the CPB circuit?

Blood Cells, Molecules, and Diseases

Volumn 34, Issue 2, 2005, Pages 144-150

  Bull, Brian S ^a   Hay, Karen ^a   Razzouk, Anees J ^a   Huse, Wilfred M ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b St Helena Hospital   (United States)

Author keywords

Blood loss, postoperative; Blood loss, surgical; Cardiopulmonary bypass; Coronary artery bypass; Thrombin; Transfusion, red blood cell

Indexed keywords

FIBRIN; FIBRINOGEN; THROMBIN; THROMBOPLASTIN;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; BLOOD DONOR; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; INSTRUMENTATION; LAPAROTOMY; NORMAL HUMAN; PERICARDIUM; PRIORITY JOURNAL; PROTEIN CONTENT;

GOSSYPIUM HIRSUTUM;

EID: 13844293994     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2004.11.003     Document Type: Article

References (35)

1. W. Fassin, D. Himpe, J.P. Alexander, S. Borms, W. Theunissen, P. Muylaert, and P. Van Cauwelaert Predictive value of coagulation testing in cardiopulmonary bypass surgery Acta Anaesthesiol. Belg. 42 1991 191 198
2. G.J. Despotis, K.S. Filos, T.N. Zoys, C.W. Hogue Jr., E. Spitznagel, and D.G. Lappas Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients Anesth. Analg. 82 1996 13 21
3. L.H. Edmunds Jr. Inflammatory response to cardiopulmonary bypass Ann. Thorac. Surg. 66 1998 S12 S16
4. E.M. Boyle Jr., T.H. Pohlman, M.C. Johnson, and E.D. Verrier Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response Ann Thorac. Surg. 63 1997 277 284
5. D. Paparella, T.M. Yau, and E. Young Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update Eur. J. Cardio-thorac. Surg. 21 2002 232 244
6. R.C. Bone, R.A. Balk, F.B. Cerra, R.P. Dellinger, A.M. Fein, W.A. Knaus, and R.M. Schein Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 101 1992 1644 1655
7. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit. Care Med. 20 1992 864 874
8. R.C. Bone Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome) JAMA 268 1992 3452 3455
9. P.D. Raymond, and N.A. Marsh Alterations to haemostasis following cardiopulmonary bypass and the relationship of these changes to neurocognitive morbidity Blood Coagul. Fibrinolysis 12 2001 601 618
10. S.J. Fearn, R. Pole, M. Burgess, S.G. Ray, T.L. Hooper, and C.N. McCollum Cerebral embolisation during modern cardiopulmonary bypass Eur. J. Cardiothorac. Surg. 20 2001 1163 1167
11. S.J. Fearn, R. Pole, K. Wesnes, E.B. Faragher, T.L. Hooper, and C.N. McCollum Cerebral injury during cardiopulmonary bypass: emboli impair memory J. Thorac. Cardiovasc. Surg. 121 2001 1150 1160
12. K. Caglar, Y. Peng, L.B. Pupim, P.J. Flakoll, D. Levenhagen, R.M. Hakim, and T.A. Ikizler Inflammatory signals associated with hemodialysis Kidney Int. 62 2002 1408 1416
13. S.F. Khuri, J.A. Wolfe, M. Josa, T.C. Axford, I. Szymanski, S. Assousa, and G. Ragno Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss J. Thorac. Cardiovasc. Surg. 104 1992 94 107
14. A. Wahba, G. Rothe, H. Lodes, S. Barlage, and G. Schmitz The influence of the duration of cardiopulmonary bypass on coagulation, fibrinolysis and platelet function Thorac. Cardiovasc. Surg. 49 2001 153 156
15. M.J. Ray, N.A. Marsh, and G.A. Hawson Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass Blood Coagul. Fibrinolysis 5 1994 679 685
16. A. Parolari, S. Colli, L. Mussoni, S. Eligini, M. Naliato, X. Wang, and S. Gandini Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery J. Thorac. Cardiovasc. Surg. 125 2003 336 343
17. J. Kappelmayer, A. Bernabei, L.H. Edmunds, T.S. Edgington, and R.W. Colman Tissue factor is expressed on monocytes during simulated extracorporeal-circulation Circ. Res. 72 1993 1075 1081
18. J.H. Chung, N. Gikakis, A.K. Rao, T.A. Drake, R.W. Colman, and L.H. Edmunds Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass Circulation 93 1996 2014 2018
19. R.M. Barstad, E. Ovrum, M.A. Ringdal, R. Oystese, M.J.A.G. Hamers, O.P. Veiby, and T. Rolfsen Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit Br. J. Haematol. 94 1996 517 525
20. E.N. Morgan, T.H. Pohlman, C. Vocelka, A. Farr, G. Lindley, W. Chandler, and J.M. Griscavage-Ennis Nuclear factor kappa B mediates a procoagulant response in monocytes during extracorporeal circulation J. Thorac. Cardiovasc. Surg. 125 2003 165 171
21. M.D. Boisclair, D.A. Lane, H. Philippou, M.P. Esnouf, S. Sheikh, B. Hunt, and K.J. Smith Mechanisms of thrombin generation during surgery and cardiopulmonary bypass Blood 82 1993 3350 3357
22. J.F. Burman, H.I. Chung, D.A. Lane, H. Philippou, A. Adami, and J.C.R. Lincoln Role of factor-XII in thrombin generation and fibrinolysis during cardiopulmonary bypass Lancet 344 1994 1192 1193
23. K.L. Hay, and B.S. Bull Rapid-SF: a rapid whole-blood screen for soluble fibrin monomer Thromb. Haemost. 88 2002 773 780
24. K.E. Brummel, S.G. Paradis, S. Butenas, and K.G. Mann Thrombin functions during tissue factor-induced blood coagulation Blood 100 2002 148 152
25. H.C. Hemker, and M.C.E. Dam-Mieras Handbook of Synthetic Substrates for the Coagulation and Fibrinolytic system 1983 Nijhoff The Hague 96 97
26. C.Y. Liu, H.L. Nossel, and K.L. Kaplan The binding of thrombin by fibrin J. Biol. Chem. 254 1979 10421 10425
27. M. Kaminski, and J. Mcdonagh Inhibited thrombins-Interactions with fibrinogen and fibrin Biochem. J. 242 1987 881 887
28. J.I. Weitz, M. Hudoba, D. Massel, J. Maraganore, and J. Hirsh Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors J. Clin. Invest. 86 1990 385 391
29. M.R. Buchanan, G.A. Maclean, and S.J. Brister Selective and sustained inhibition of surface-bound thrombin activity by intimatan/heparin cofactor II and its relevance to assessing systemic anticoagulation in vivo, ex vivo and in vitro Thromb. Haemost. 86 2001 909 913
30. Heart disease and stroke statistics. American Heart Association (Accessed 10/14/2004 at http://www.americanheart.org)
31. Annual blood transfusions in USA. American Association of Blood Banks (AABB) (Accessed 10/14/2004 at http://www.aabb.org/)
32. C.T. Esmon Crosstalk between inflammation and thrombosis Maturitas 47 2004 305 314
33. B. Stutz Pumphead Sci. Am. 289 2003 76 81
34. R.F. Brooker, W.R. Brown, D.M. Moody, J.W. Hammon Jr., D.M. Reboussin, D.D. Deal, and H.S. Ghazi-Birry Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass Ann. Thorac. Surg. 65 1998 1651 1655
35. A.K. Kaza, J.T. Cope, S.M. Fiser, S.M. Long, J.A. Kern, I.L. Kron, and C.G. Tribble Elimination of fat microemboli during cardiopulmonary bypass Ann. Thorac. Surg. 75 2003 555 559